Story perspectives

Rising GLP-1 Use Sparks Unplanned Pregnancies Among Women

9/10/2025

Summary

Story summary

In Australia, GLP-1 receptor agonists are increasingly prescribed for weight management in women of reproductive age, often without a diabetes diagnosis.
A study revealed that only 21% of these women used contraception, with 2.2% becoming pregnant within six months.
Weight loss may improve fertility, leading to unplanned pregnancies, particularly in women with polycystic ovary syndrome.
The Institute for Clinical and Economic Review noted GLP-1 drugs are cost-effective but raise affordability concerns.
Gastrointestinal side effects often lead to treatment discontinuation. ICER's final report on GLP-1 drugs will be released on December 19, 2025.

1 of 1

Story summary

In Australia, GLP-1 receptor agonists are increasingly prescribed for weight management in women of reproductive age, often without a diabetes diagnosis.
A study revealed that only 21% of these women used contraception, with 2.2% becoming pregnant within six months.
Weight loss may improve fertility, leading to unplanned pregnancies, particularly in women with polycystic ovary syndrome.
The Institute for Clinical and Economic Review noted GLP-1 drugs are cost-effective but raise affordability concerns.
Gastrointestinal side effects often lead to treatment discontinuation. ICER's final report on GLP-1 drugs will be released on December 19, 2025.